The mechanism elucidation of the protective effect of prostanoids in ischemic myocardial protection
| Project/Area Number |
20590244
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
General pharmacology
|
|---|
| Research Institution | Asahikawa Medical College |
|---|
Principal Investigator |
YUHKI Koh-Ichi Asahikawa Medical College, 医学部, 講師 (80302420)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | プロスタノイド / プロスタグランジンE_2 / 心筋梗塞 / プレコンディショニング / 受容体欠損マウス / 虚血-再灌流障害 |
|---|
| Research Abstract |
Prostanoids are bioactive lipid mediators consisting of prostaglandins (PGs) and thromboxanes. On the other hand, Ischemic preconditioning (IPC) is a phenomenon that a brief ischemia of the heart induces a potent cardioprotective mechanism upon a succeeding ischemic insult. This research was analyzed about the roles of prostanoids in the ischemic heart disease using mice lacking PGE_2 receptor. We demonstrated that the PGE_2-EP_4 system exerts the cardio-protective effect in the late phase of IPC partly by augmenting the anti-apoptosis related signaling.
|
Report
(4 results)
Research Products
(22 results)
-
-
-
-
[Journal Article] Selective activation of the prostaglandin E_2 receptor subtype EP_2 or EP_4 leads to inhibition of platelet aggregation.2010
Author(s)
Kuriyama S, Kashiwagi H, , Yuhki K, Kojima F, Yamada T, Fujino T, Hara A, Takayama K, Maruyama T, Yoshida A, Narumiya S, Ushikubi F
-
Journal Title
Thromb.Haemost. 104
Pages: 796-803
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
